Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 15:1284:135409.
doi: 10.1016/j.molstruc.2023.135409. Epub 2023 Mar 23.

Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease

Affiliations

Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease

Ze-Jun Jia et al. J Mol Struct. .

Abstract

The outbreak of novel coronavirus disease 2019 (COVID-19), caused by the novel coronavirus (SARS-CoV-2), has had a significant impact on human health and the economic development. SARS-CoV-2 3CL protease (3CLpro) is highly conserved and plays a key role in mediating the transcription of virus replication. It is an ideal target for the design and screening of anti-coronavirus drugs. In this work, seven β-nitrostyrene derivatives were synthesized by Henry reaction and β-dehydration reaction, and their inhibitory effects on SARS-CoV-2 3CL protease were identified by enzyme activity inhibition assay in vitro. Among them, 4-nitro-β-nitrostyrene (compound a) showed the lowest IC50 values of 0.7297 µM. To investigate the key groups that determine the activity of β-nitrostyrene derivatives and their interaction mode with the receptor, the molecular docking using the CDOCKER protocol in Discovery Studio 2016 was performed. The results showed that the hydrogen bonds between β-NO2 and receptor GLY-143 and the π-π stacking between the aryl ring of the ligand and the imidazole ring of receptor HIS-41 significantly contributed to the ligand activity. Furthermore, the ligand-receptor absolute binding Gibbs free energies were calculated using the Binding Affinity Tool (BAT.py) to verify its correlation with the activity of β-nitrostyrene 3CLpro inhibitors as a scoring function. The higher correlation(r2=0.6) indicates that the absolute binding Gibbs free energy based on molecular dynamics can be used to predict the activity of new β-nitrostyrene 3CLpro inhibitors. These results provide valuable insights for the functional group-based design, structure optimization and the discovery of high accuracy activity prediction means of anti-COVID-19 lead compounds.

Keywords: 3CLpro inhibitor; Binding Gibbs free energies; Molecular docking; Receptor-ligand interaction; SARS-CoV-2; β-nitrostyrene derivatives.

PubMed Disclaimer

Conflict of interest statement

All co-authors declare that there are no conflicts of interest.

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig. 1
FTIR spectroscopy of compound a-g.
Fig 2
Fig. 2
Dose-response curves for IC50 determination of compounds a-g were generated by nonlinear regression and are shown in pictures A-G, respectively.
Fig 3
Fig. 3
Binding modes between ligands and 3CL protease. Picture A-G show interactions between β-nitrostyrene derivatives and protein amino acids in 3D mode and distance between two atoms in unit Å. Picture I-VII show interactions between β-nitrostyrene derivatives and protein amino acids in 2D mode by DS 2016. Picture H show the results of docking the ligand H69 to the original structure of the complex (PDB ID:7RN4) for retrospective studies. The result of molecular docking is indicated in cyans, and the pose of H69 in the original crystal structure is indicated by magenta.
Fig 3
Fig. 3
Binding modes between ligands and 3CL protease. Picture A-G show interactions between β-nitrostyrene derivatives and protein amino acids in 3D mode and distance between two atoms in unit Å. Picture I-VII show interactions between β-nitrostyrene derivatives and protein amino acids in 2D mode by DS 2016. Picture H show the results of docking the ligand H69 to the original structure of the complex (PDB ID:7RN4) for retrospective studies. The result of molecular docking is indicated in cyans, and the pose of H69 in the original crystal structure is indicated by magenta.
Fig 3
Fig. 3
Binding modes between ligands and 3CL protease. Picture A-G show interactions between β-nitrostyrene derivatives and protein amino acids in 3D mode and distance between two atoms in unit Å. Picture I-VII show interactions between β-nitrostyrene derivatives and protein amino acids in 2D mode by DS 2016. Picture H show the results of docking the ligand H69 to the original structure of the complex (PDB ID:7RN4) for retrospective studies. The result of molecular docking is indicated in cyans, and the pose of H69 in the original crystal structure is indicated by magenta.
Fig 4
Fig. 4
Correlation between the IC50 of seven inhibitors and binding Gibbs free energy. A linear regression shows that lower binding Gibbs free energy correlates with stronger 3CL protease inhibition.
Scheme 1
Scheme 1
Synthesis of β-Nitrostyrene derivatives.

Similar articles

Cited by

References

    1. Toit A.Du. Outbreak of a novel coronavirus. Nat. Rev. Microbiol. 2020;18(3):123. - PMC - PubMed
    1. Bassetti M., Vena A., Giacobbe D.R. The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm. Eur. J. Clin. Invest. 2020;50(3):e13209. - PMC - PubMed
    1. Hui D.S.C., Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect. Dis. Clin. North Am. 2019;33(4):869–889. - PMC - PubMed
    1. Health World. Organization COVID-19 vaccine tracker. and landscape. 2022
    1. Hashimoto M., Nagata N., Homma T., Maeda H., Dohi K., Seki N.M., Yoshihara K., Iwata-Yoshikawa N., Shiwa-Sudo N., Sakai Y., Shirakura M., Kishida N., Arita T., Suzuki Y., Watanabe S., Asanuma H., Sonoyama T., Suzuki T., Omoto S., Hasegawa H. Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys. Vaccine. 2022;40(31):4231–4241. - PMC - PubMed